LEXEO Therapeutics Appoints Micah Zajic as Chief Financial Officer and Paula H. J. Cholmondeley as Board of Directors Audit Committee Chair
Cholmondeley to its Board of Directors as Audit Committee Chair.
- Cholmondeley to its Board of Directors as Audit Committee Chair.
- Micah Zajic has been appointed Chief Financial Officer at LEXEO.
- Mr. Zajic brings nearly 20 years of experience in biotech corporate development, healthcare capital markets and investment banking to LEXEO.
- Mr. Zajic most recently served as Chief Financial Officer at SQZ Biotechnologies (NYSE).